Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $5.73B | $5.34B | +7.47% |
Cost of Revenue | $770.5M | $714.5M | +7.84% |
Operating Income | $1.78B | $-2.38B | +174.99% |
Net Income | $1.68B | $-2.49B | +167.33% |
EPS (Basic) | $6.54 | $-9.66 | +167.70% |
EPS (Diluted) | $6.48 | $-9.66 | +167.08% |
SG&A Expense | $821M | $714.9M | +14.84% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $24.04B | $20.13B | +19.39% |
Current Assets | $10.43B | $8.94B | +16.62% |
Total Liabilities | $6.86B | $5.36B | +28.07% |
Current Liabilities | $4.14B | $3.55B | +16.67% |
Stockholders' Equity | $17.18B | $14.77B | +16.25% |
Cash & Equivalents | $4.97B | $4.58B | +8.56% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $1.89B | $-2.45B | +177.32% |
Investing Cash Flow | $-540.3M | $-2.6B | +79.22% |
Financing Cash Flow | $-1.03B | $-716.1M | -43.78% |
Share Buybacks | $817.9M | $451.5M | +81.15% |
D&A | $100.1M | $107.5M | -6.88% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | 31.1% | -44.5% | +75.57% |
Net Margin | 29.3% | — | — |
ROE | 9.8% | — | — |
ROA | 7.0% | — | — |
Current Ratio | $2.52 | — | — |
Debt to Equity | $0.399 | — | — |
Other companies in Biotechnology